Predictive Value of Preclinical Toxicology Studies for Platinum Anticancer Drugs

Rodent and nonrodent toxicology studies are currently expected to support Phase I trials of antineoplastic drugs in the United States. To determine the predictive value of these studies, we initiated a project to compare preclinical and clinical toxicity data within various drug classes. The first c...

Ausführliche Beschreibung